PIR and breast carcinoma: However, piR-823 has been shown to inhibit gastric carcinogenesis [100] and induces the expression of stem cell markers (including OCT4, SOX2, KLF4, NANOG, and hTERT) and increases the formation of mammospheres, as has been demonstrated on breast cancer MCF-7 and T-47D cells.